Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne Kamel-Reid

Showing results (1-10 of 158) with videos related to

Pageof 16
Sort By:
Journal of Clinical Pathology|October 23, 2017
T cell clonality assessment: past, present and futureEtienne Mahe, Tevor Pugh, Suzanne Kamel-Reid
Oncogene|September 26, 2003
Expression of NPM-RARalpha fusion gene in hematopoietic cells confers sensitivity to troglitazone-induced apoptosisSuzanne Kamel-Reid, Tong Zhang, Richard A Wells
Leukemia Research|June 20, 2012
An emerging role for retinoid X receptor α in malignant hematopoiesisMariam Thomas, Mahadeo A Sukhai, Suzanne Kamel-Reid
The Journal of Molecular Diagnostics : JMD|July 2, 2013
BCR-ABL1 RT-qPCR for monitoring the molecular response to tyrosine kinase inhibitors in chronic myeloid leukemiaRichard D Press, Suzanne Kamel-Reid, Daphne Ang
Saudi Medical Journal|August 3, 2006
Lack of evidence of Epstein-Barr virus infection in patients with Castleman's disease. Molecular genetic analysisJaudah Al-Maghrabi, Suzanne Kamel-Reid, Denis J Bailey
American Journal of Hematology|February 16, 2007
Inv (11)(p15q21) in donor-derived Ph-negative cells in a patient with chronic myeloid leukemia in relapse successfully treated with imatinib mesylate post allogeneic stem cell transplantationBruno C Medeiros, Kathy Chun, Suzanne Kamel-Reid, et al.
Neurosciences (Riyadh, Saudi Arabia)|January 24, 2012
Lack of evidence of Epstein-Barr virus infection in patients with Castleman`s disease. Molecular genetic analysisJaudah A Al-Maghrabi, Suzanne Kamel-Reid, Denis J Bailey
Leukemia Research|August 6, 2010
Prognostic factors in normal karyotype acute myeloid leukemia in the absence of the FLT3-ITD mutationAllan Jiang, Hua Jiang, Joseph Brandwein, et al.
Human Pathology|September 4, 2012
Prognostic value of immunophenotyping and gene mutations in elderly patients with acute myeloid leukemia with normal karyotypeHarry Dang, Allan Jiang, Suzanne Kamel-Reid, et al.
British Journal of Haematology|January 3, 2013
BCR-ABL1 transcript at 3 months predicts long-term outcomes following second generation tyrosine kinase inhibitor therapy in the patients with chronic myeloid leukaemia in chronic phase who failed ImatinibDennis D Kim, Honggi Lee, Suzanne Kamel-Reid, et al.
Pageof 16

Showing results (1-10 of 158) with videos related to

Sort By:
Pageof 16
Journal of Clinical Pathology|October 23, 2017
T cell clonality assessment: past, present and futureEtienne Mahe, Tevor Pugh, Suzanne Kamel-Reid
Oncogene|September 26, 2003
Expression of NPM-RARalpha fusion gene in hematopoietic cells confers sensitivity to troglitazone-induced apoptosisSuzanne Kamel-Reid, Tong Zhang, Richard A Wells
Leukemia Research|June 20, 2012
An emerging role for retinoid X receptor α in malignant hematopoiesisMariam Thomas, Mahadeo A Sukhai, Suzanne Kamel-Reid
The Journal of Molecular Diagnostics : JMD|July 2, 2013
BCR-ABL1 RT-qPCR for monitoring the molecular response to tyrosine kinase inhibitors in chronic myeloid leukemiaRichard D Press, Suzanne Kamel-Reid, Daphne Ang
Saudi Medical Journal|August 3, 2006
Lack of evidence of Epstein-Barr virus infection in patients with Castleman's disease. Molecular genetic analysisJaudah Al-Maghrabi, Suzanne Kamel-Reid, Denis J Bailey
American Journal of Hematology|February 16, 2007
Inv (11)(p15q21) in donor-derived Ph-negative cells in a patient with chronic myeloid leukemia in relapse successfully treated with imatinib mesylate post allogeneic stem cell transplantationBruno C Medeiros, Kathy Chun, Suzanne Kamel-Reid, et al.
Neurosciences (Riyadh, Saudi Arabia)|January 24, 2012
Lack of evidence of Epstein-Barr virus infection in patients with Castleman`s disease. Molecular genetic analysisJaudah A Al-Maghrabi, Suzanne Kamel-Reid, Denis J Bailey
Leukemia Research|August 6, 2010
Prognostic factors in normal karyotype acute myeloid leukemia in the absence of the FLT3-ITD mutationAllan Jiang, Hua Jiang, Joseph Brandwein, et al.
Human Pathology|September 4, 2012
Prognostic value of immunophenotyping and gene mutations in elderly patients with acute myeloid leukemia with normal karyotypeHarry Dang, Allan Jiang, Suzanne Kamel-Reid, et al.
British Journal of Haematology|January 3, 2013
BCR-ABL1 transcript at 3 months predicts long-term outcomes following second generation tyrosine kinase inhibitor therapy in the patients with chronic myeloid leukaemia in chronic phase who failed ImatinibDennis D Kim, Honggi Lee, Suzanne Kamel-Reid, et al.
Pageof 16